- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04973202
Portrayal of Hospital Alcohol Detoxification in France (Alcostop)
Portrayal of Hospital Alcohol Detoxifications and Factors Associated With Longer or Ulterior Hospitalizations in France From 2011 to 2020
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Context:
In France, the consequences of excessive alcohol use are one of the primary reasons for hospitalization. When stopping the substance, patients with an alcohol use disorder can suffer from a potentially fatal alcohol withdrawal syndrome. To mitigate these risks, a withdrawal under medical supervision is possible, either in an outpatient setting or in hospital, where the detoxification can be programmed or imposed. In the course of an alcohol dependent patient's life, re-drinking is not exceptional and the patient may undergo several withdrawals during his or her life.
Psychiatric pathologies, especially anxiety and depression, are more frequent in these patients than in the rest of the population, just as can be somatic pathologies.e. Withdrawal accidents, represented by comital seizures and delirium tremens, can be critical.
In hospital detoxifications, studies do not show any benefit in continuing the stay beyond 10 days, except in the case of somatic or psychiatric complication. However, little information is available on the average length of stay for hospital alcohol detoxification.
Although alcohol dependence issues are very frequent and the resulting withdrawals are relatively common and associated with numerous comorbidities, little data exists at a national level in France.
The aim of this study is to describe these hospital detoxifications: course, duration, frequency and clinical and paraclinical characteristics of the patients. We also wish to analyze which characteristics are associated with longer stays or re-hospitalization and to compare the care according to the facility type.
Objectives:
Main:
- To describe the clinical, paraclinical, and stay characteristics of hospital alcohol detoxification in France
Secondary:
- To describe the regional distribution of hospital alcohol detoxification
- To evaluate whether certain clinical characteristics are associated with a longer hospital stays
- To evaluate whether certain clinical characteristics are associated with subsequent re-hospitalization for the same reason
- To compare the characteristics of patient stays by type of facility
Methods:
In this descriptive observational study using pre-existing data accessed via the PMSI (Programme de Médicalisation des Systèmes d'Information), we will use all hospital stays from 2011 to 2020 for alcohol detoxification in France, both in public and private settings.
For each hospital stay will be collected the length, the antecedents of hospital alcohol detoxification, clinical and psychiatric comorbidities, withdrawals complication, alcohol use complication, further examinations.
We will describe the stays using median and quartiles for continuous variables and number and percentage for dichotomous variables. For secondary objectives, we will use a multivariate linear regression model if the length of stay is normal, an ordinal regression model otherwise. The characteristics of the stays will be compared regarding the type of facility using univariate comparative tests: Chi² or Fisher for dichotomous variables and Student or Mann-Whitney for continuous variables.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
-
Montpellier, França, 34295
- Uhmontpellier
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion criteria:
Inclusion criteria:
- French patients of at least 18 years old
- Inpatients of a public or private care facility for alcohol detoxification
- From 01/01/2011 to 12/31/2020
- In a medical or psychiatric hospital
Exclusion criteria:
- age < 18 years
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
---|---|
Inpatients for alcohol detoxifications
French patients who were hospitalized for alcohol detoxification from 2011 to 2020
|
Stay for alcohol detoxification : routine care.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
description of age
Prazo: day 1 (At hospital inclusion)
|
Age at admission (in years), calculated by the difference of the year of admission and the year of birth through the PMSI.
|
day 1 (At hospital inclusion)
|
description of sex
Prazo: day 1 (At hospital inclusion)
|
Sex collected through the PMSI.
|
day 1 (At hospital inclusion)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
description of geographic code
Prazo: day 1 (At hospital inclusion)
|
Sex collected through the PMSI.
|
day 1 (At hospital inclusion)
|
description of CMU-C
Prazo: day 1 (At hospital inclusion)
|
CMU-C (universal complementary health insurance, collected through the PMSI.
|
day 1 (At hospital inclusion)
|
Length of stay
Prazo: During the stay (day 1 - day 15)
|
Length of stay (in days), calculated by the difference between the discharge date and the entry date, collected through the PMSI.
|
During the stay (day 1 - day 15)
|
Care establishment
Prazo: During the stay (day 1 - day 15)
|
Name and type of the care establishment, collected through the PMSI.
|
During the stay (day 1 - day 15)
|
Number of previous hospital detoxification stays in the studied period
Prazo: During the stay (day 1 - day 15)
|
Number of previous hospital detoxification stays in the studied period, collected through the PMSI.
|
During the stay (day 1 - day 15)
|
Psychiatric comorbidities
Prazo: During the stay (day 1 - day 15)
|
Psychiatric comorbidities (Major depression episode, anxiety, psychotic trouble, personality diseases), collected through the PMSI.
|
During the stay (day 1 - day 15)
|
Withdrawal complication
Prazo: During the stay (day 1 - day 15)
|
Withdrawal complications (delirium tremens, comitial seizures), collected through the PMSI.
|
During the stay (day 1 - day 15)
|
Further examination
Prazo: During the stay (day 1 - day 15)
|
Further examination (biology, imagery, etc…), collected through the PMSI.
|
During the stay (day 1 - day 15)
|
Re-hospitalization for same reason
Prazo: day 1
|
For each patient, and each stay, we will evaluate if the patient had an ulterior re-hospitalization for alcohol withdrawal.
Collected through the PMSI.
|
day 1
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Lionel MOULIS, University Hospital, Montpellier
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- RECHMPL21_0456
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Stay for alcohol detoxification
-
University of KansasUniversity of North CarolinaRecrutamentoTranstorno do Espectro AutistaEstados Unidos
-
Central Hospital, Nancy, FranceConcluídoSuicídio e AutomutilaçãoFrança
-
Division of General Surgery , Mt. Sinai HospitalConcluídoDoenças Inflamatórias Intestinais | Câncer colorretal | Cirurgia | Utilização, cuidados de saúde | Monitoramento pós-altaCanadá
-
Michigan State UniversityHenry Ford Health System; Butler Hospital; Pacific Institute for Research and...RecrutamentoDepressão pós-partoEstados Unidos
-
Chinese University of Hong KongConcluídoDoença cardiovascular | Insuficiência renal | ESRDHong Kong
-
University of Kansas Medical CenterRecrutamentoTranstorno do Espectro Autista | Comunicação não verbalEstados Unidos
-
Uppsala UniversityRegion Stockholm; Uppsala County Council, Sweden; National Social Insurance Board... e outros colaboradoresConcluído
-
University of SevilleMaastricht University; Junta de AndalucíaConcluídoBeber álcool | Beber em excesso | Comportamento adolescenteEspanha
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)ConcluídoDoenças do Fígado | Distúrbios Relacionados ao ÁlcoolEstados Unidos
-
University of SevilleMaastricht University; Delegación del Gobierno para el Plan Nacional sobre DrogasConcluídoBeber álcool | Beber em excesso | Comportamento adolescenteEspanha